Ontario health technology assessment series
[No authors listed]
PMID: 23074400
Ont Health Technol Assess Ser. 2010;10(22):1-28. Epub 2010 Dec 01.
No abstract available.
Cite
Negative pressure wound therapy: an evidence update. Ont Health Technol Assess Ser. 2010;10(22):1-28
(2010). Negative pressure wound therapy: an evidence update. Ontario health technology assessment series, 10(22), 1-28.
"Negative pressure wound therapy: an evidence update." Ontario health technology assessment series vol. 10,22 (2010): 1-28.
Negative pressure wound therapy: an evidence update. Ont Health Technol Assess Ser. 2010;10(22):1-28. Epub 2010 Dec 01. PMID: 23074400; PMCID: PMC3377568.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074402
Ont Health Technol Assess Ser. 2010;10(24):1-48. Epub 2010 Dec 01.
UNLABELLED: In February 2010, the Medical Advisory Secretariat (MAS) began work on evidence-based reviews of the literature surrounding three pharmacogenomic tests. This project came about when Cancer Care Ontario (CCO) asked MAS to provide evidence-based analyses on the effectiveness...
Cite
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser. 2010;10(24):1-48
(2010). Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ontario health technology assessment series, 10(24), 1-48.
"Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis." Ontario health technology assessment series vol. 10,24 (2010): 1-48.
Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis. Ont Health Technol Assess Ser. 2010;10(24):1-48. Epub 2010 Dec 01. PMID: 23074402; PMCID: PMC3377519.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074403
Ont Health Technol Assess Ser. 2010;10(25):1-49. Epub 2010 Dec 01.
LITERATURE SEARCH: The Medical Advisory Secretariat followed its standard procedures and on May 18, 2010, searched the following electronic databases: Ovid MEDLINE, EMBASE, Ovid MEDLINE In-Process & Other Non-Indexed Citations, Cochrane Central Register of Controlled Trials, Cochrane Database of...
Cite
KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis. Ont Health Technol Assess Ser. 2010;10(25):1-49
(2010). KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis. Ontario health technology assessment series, 10(25), 1-49.
"KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis." Ontario health technology assessment series vol. 10,25 (2010): 1-49.
KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis. Ont Health Technol Assess Ser. 2010;10(25):1-49. Epub 2010 Dec 01. PMID: 23074403; PMCID: PMC3377508.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074418
Ont Health Technol Assess Ser. 2011;11(6):1-58. Epub 2011 Nov 01.
PRIMARY OUTCOME: ARM MOTOR FUNCTION: Action Research Arm Test (ARAT) SECONDARY OUTCOME: ARM MOTOR IMPAIRMENT: Fugl-Meyer Motor Assessment (FMA)ACTIVITIES OF DAILY LIVING (ADL): Functional Independence Measure (FIM), Chedoke Arm and Hand InventoryPERCEIVED MOTOR FUNCTION: Motor Activity Log (MAL) Amount...
Cite
Constraint-induced movement therapy for rehabilitation of arm dysfunction after stroke in adults: an evidence-based analysis. Ont Health Technol Assess Ser. 2011;11(6):1-58
(2011). Constraint-induced movement therapy for rehabilitation of arm dysfunction after stroke in adults: an evidence-based analysis. Ontario health technology assessment series, 11(6), 1-58.
"Constraint-induced movement therapy for rehabilitation of arm dysfunction after stroke in adults: an evidence-based analysis." Ontario health technology assessment series vol. 11,6 (2011): 1-58.
Constraint-induced movement therapy for rehabilitation of arm dysfunction after stroke in adults: an evidence-based analysis. Ont Health Technol Assess Ser. 2011;11(6):1-58. Epub 2011 Nov 01. PMID: 23074418; PMCID: PMC3377570.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074446
Ont Health Technol Assess Ser. 2003;3(6):1-82. Epub 2003 Nov 01.
OBJECTIVE: The objective of this health technology policy assessment was to determine the effectiveness safety and cost-effectiveness of using functional cardiac magnetic resonance imaging (MRI) for the assessment of myocardial viability and perfusion in patients with coronary artery disease...
Cite
Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis. Ont Health Technol Assess Ser. 2003;3(6):1-82
(2003). Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis. Ontario health technology assessment series, 3(6), 1-82.
"Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis." Ontario health technology assessment series vol. 3,6 (2003): 1-82.
Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis. Ont Health Technol Assess Ser. 2003;3(6):1-82. Epub 2003 Nov 01. PMID: 23074446; PMCID: PMC3387764.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074457
Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 01.
OBJECTIVE: This review was conducted to assess the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder (MDD).THE TECHNOLOGY: rTMS is a noninvasive way to stimulate nerve cells in areas of the brain. During...
Cite
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4(7):1-98
(2004). Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ontario health technology assessment series, 4(7), 1-98.
"Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis." Ontario health technology assessment series vol. 4,7 (2004): 1-98.
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 01. PMID: 23074457; PMCID: PMC3387754.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074468
Ont Health Technol Assess Ser. 2005;5(17):1-52. Epub 2005 Nov 01.
OBJECTIVE: This health technology policy assessment will answer the following questions: When should in-room air cleaners be used?How effective are in-room air cleaners?Are in-room air cleaners that use combined HEPA and UVGI air cleaning technology more effective than those...
Cite
Air cleaning technologies: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(17):1-52
(2005). Air cleaning technologies: an evidence-based analysis. Ontario health technology assessment series, 5(17), 1-52.
"Air cleaning technologies: an evidence-based analysis." Ontario health technology assessment series vol. 5,17 (2005): 1-52.
Air cleaning technologies: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(17):1-52. Epub 2005 Nov 01. PMID: 23074468; PMCID: PMC3382390.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074474
Ont Health Technol Assess Ser. 2005;5(5):1-57. Epub 2005 Apr 01.
PURPOSE: Computed tomography (CT) scanning continues to be an important modality for the diagnosis of injury and disease, most notably for indications of the head and abdomen. (1) According to a recent report published by the Canadian Institutes of...
Cite
Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(5):1-57
(2005). Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis. Ontario health technology assessment series, 5(5), 1-57.
"Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis." Ontario health technology assessment series vol. 5,5 (2005): 1-57.
Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(5):1-57. Epub 2005 Apr 01. PMID: 23074474; PMCID: PMC3382628.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074487
Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 01.
OBJECTIVE: The Ontario Health Technology Advisory Committee asked the Medical Advisory Secretariat (MAS) to conduct a health technology assessment on energy delivery systems for the treatment of benign prostatic hyperplasia (BPH).CLINICAL NEED: TARGET POPULATION AND CONDITION BPH is a...
Cite
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(17):1-121
(2006). Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ontario health technology assessment series, 6(17), 1-121.
"Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis." Ontario health technology assessment series vol. 6,17 (2006): 1-121.
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 01. PMID: 23074487; PMCID: PMC3379165.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074500
Ont Health Technol Assess Ser. 2006;6(9):1-31. Epub 2006 Mar 01.
OBJECTIVE: To review the evidence on the effectiveness of hydrophilic catheters for patients requiring intermittent catheterization.CLINICAL NEED: There are various reasons why a person would require catheterization, including surgery, urinary retention due to enlargement of the prostate, spinal cord...
Cite
Hydrophilic catheters: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(9):1-31
(2006). Hydrophilic catheters: an evidence-based analysis. Ontario health technology assessment series, 6(9), 1-31.
"Hydrophilic catheters: an evidence-based analysis." Ontario health technology assessment series vol. 6,9 (2006): 1-31.
Hydrophilic catheters: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(9):1-31. Epub 2006 Mar 01. PMID: 23074500; PMCID: PMC3386556.
Copy
Download .nbib
Ontario health technology assessment series
[No authors listed]
PMID: 23074506
Ont Health Technol Assess Ser. 2008;8(1):1-41. Epub 2008 Oct 01.
No abstract available.
Cite
Aging in the community: summary of evidence-based analyses. Ont Health Technol Assess Ser. 2008;8(1):1-41
(2008). Aging in the community: summary of evidence-based analyses. Ontario health technology assessment series, 8(1), 1-41.
"Aging in the community: summary of evidence-based analyses." Ontario health technology assessment series vol. 8,1 (2008): 1-41.
Aging in the community: summary of evidence-based analyses. Ont Health Technol Assess Ser. 2008;8(1):1-41. Epub 2008 Oct 01. PMID: 23074506; PMCID: PMC3377555.
Copy
Download .nbib